MedAvail Holdings, Inc. (Nasdaq: MDVL) announced its financial results for Q3 2021 will be reported on November 8, 2021, after market close. A conference call will follow at 1:30 p.m. PT / 4:30 p.m. ET. MedAvail provides in-clinic pharmacy services via its proprietary robotic dispensing platform, aiming to improve drug adherence and health outcomes for Medicare clinics. Investors can access the live webcast on its Investor Relations page.
Focus on Medicare clinics supports a growing market segment.
Negative
No immediate financial metrics or guidance provided ahead of earnings report.
Insights
Analyzing...
MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--
MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today announced it will report financial results for the third quarter 2021 on Monday, November 8, 2021, after market close. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the “Investor Relations” section of the Company’s website at: https://investors.medavail.com/. The webcast will be archived and available for replay after the event.
About MedAvail
MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.